These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 12431334)

  • 1. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
    Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S
    Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
    Mukherjee D; Mahaffey KW; Moliterno DJ; Harrington RA; Yadav JS; Pieper KS; Gallup D; Dyke C; Roe MT; Berdan L; Lauer MS; Mänttäri M; White HD; Califf RM; Topol EJ
    Am Heart J; 2002 Dec; 144(6):995-1002. PubMed ID: 12486423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
    Montalescot G; Van de Werf F; Gulba DC; Avezum A; Brieger D; Kennelly BM; Mazurek T; Spencer F; White K; Gore JM;
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):360-7. PubMed ID: 14571488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
    Lincoff AM
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction.
    De Luca G; Marino P
    Thromb Haemost; 2008 Aug; 100(2):184-95. PubMed ID: 18690336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies Against the IIb/IIIa Platelet Receptor to Treat Acute Thrombotic Occlusion of a Coronary Stent.
    Rozenman Y; Mosseri M; Mereuta A; Gotsman MS
    J Invasive Cardiol; 1998 Jan; 10(1):42-44. PubMed ID: 10762762
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary angioplasty: preprocedural pharmacological therapy.
    Ernst N; de Boer MJ; Zijlstra F; Suryapranata H; Dambrink JH; Hoorntje JC; van 't Hof AW
    Neth Heart J; 2006 Feb; 14(2):55-61. PubMed ID: 25696594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization.
    Albirini A; Brener SJ
    Int J Cardiovasc Intervent; 2001 Mar; 4(1):7-14. PubMed ID: 12431334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
    Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.